vs
Side-by-side financial comparison of National CineMedia, Inc. (NCMI) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $63.4M, roughly 1.1× National CineMedia, Inc.). National CineMedia, Inc. runs the higher net margin — 2.5% vs -49.0%, a 51.6% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 1.6%). National CineMedia, Inc. produced more free cash flow last quarter ($-2.0M vs $-84.7M).
National CineMedia, Inc. (NCM) is an American cinema advertising company. NCM displays ads to U.S. consumers in movie theaters, online and through mobile technology. NCM presents cinema advertising across a digital in-theater network, consisting of theaters owned by AMC Theatres, Cinemark Theatres, Regal Cinemas and other regional theater circuits.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
NCMI vs VRDN — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $63.4M | $70.6M |
| Net Profit | $1.6M | $-34.6M |
| Gross Margin | 95.0% | — |
| Operating Margin | -2.8% | -56.7% |
| Net Margin | 2.5% | -49.0% |
| Revenue YoY | 1.6% | 81958.1% |
| Net Profit YoY | 144.4% | 54.9% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $63.4M | $70.6M | ||
| Q2 25 | $51.8M | — | ||
| Q1 25 | $34.9M | — | ||
| Q4 24 | $86.3M | — | ||
| Q3 24 | $62.4M | — | ||
| Q2 24 | $54.7M | — | ||
| Q1 24 | $37.4M | — | ||
| Q4 23 | $90.8M | — |
| Q3 25 | $1.6M | $-34.6M | ||
| Q2 25 | $-10.7M | — | ||
| Q1 25 | $-30.7M | — | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $-3.6M | — | ||
| Q2 24 | $-8.7M | — | ||
| Q1 24 | $-34.7M | — | ||
| Q4 23 | $23.6M | — |
| Q3 25 | 95.0% | — | ||
| Q2 25 | 93.8% | — | ||
| Q1 25 | 91.1% | — | ||
| Q4 24 | 96.4% | — | ||
| Q3 24 | 94.7% | — | ||
| Q2 24 | 93.2% | — | ||
| Q1 24 | 90.4% | — | ||
| Q4 23 | 96.0% | — |
| Q3 25 | -2.8% | -56.7% | ||
| Q2 25 | -23.2% | — | ||
| Q1 25 | -68.5% | — | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | -12.0% | — | ||
| Q2 24 | -17.0% | — | ||
| Q1 24 | -60.7% | — | ||
| Q4 23 | 22.6% | — |
| Q3 25 | 2.5% | -49.0% | ||
| Q2 25 | -20.7% | — | ||
| Q1 25 | -88.0% | — | ||
| Q4 24 | 28.6% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | -15.9% | — | ||
| Q1 24 | -92.8% | — | ||
| Q4 23 | 26.0% | — |
| Q3 25 | $0.02 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.32 | — | ||
| Q4 24 | $0.26 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.36 | — | ||
| Q4 23 | $-16.75 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.9M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $350.5M | $503.0M |
| Total Assets | $451.9M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $29.9M | $490.9M | ||
| Q2 25 | $37.2M | — | ||
| Q1 25 | $59.8M | — | ||
| Q4 24 | $75.2M | — | ||
| Q3 24 | $49.5M | — | ||
| Q2 24 | $53.8M | — | ||
| Q1 24 | $57.1M | — | ||
| Q4 23 | $34.6M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $10.0M | — |
| Q3 25 | $350.5M | $503.0M | ||
| Q2 25 | $350.0M | — | ||
| Q1 25 | $370.8M | — | ||
| Q4 24 | $411.2M | — | ||
| Q3 24 | $385.5M | — | ||
| Q2 24 | $387.9M | — | ||
| Q1 24 | $402.3M | — | ||
| Q4 23 | $434.5M | — |
| Q3 25 | $451.9M | $577.1M | ||
| Q2 25 | $462.0M | — | ||
| Q1 25 | $503.8M | — | ||
| Q4 24 | $568.6M | — | ||
| Q3 24 | $526.1M | — | ||
| Q2 24 | $527.2M | — | ||
| Q1 24 | $538.6M | — | ||
| Q4 23 | $567.7M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $-84.6M |
| Free Cash FlowOCF − Capex | $-2.0M | $-84.7M |
| FCF MarginFCF / Revenue | -3.2% | -120.1% |
| Capex IntensityCapex / Revenue | 1.6% | 0.2% |
| Cash ConversionOCF / Net Profit | -0.63× | — |
| TTM Free Cash FlowTrailing 4 quarters | $24.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-1.0M | $-84.6M | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $-2.0M | — | ||
| Q2 24 | $7.7M | — | ||
| Q1 24 | $24.1M | — | ||
| Q4 23 | $15.6M | — |
| Q3 25 | $-2.0M | $-84.7M | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $28.1M | — | ||
| Q3 24 | $-2.6M | — | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $22.6M | — | ||
| Q4 23 | $14.0M | — |
| Q3 25 | -3.2% | -120.1% | ||
| Q2 25 | -12.7% | — | ||
| Q1 25 | 15.2% | — | ||
| Q4 24 | 32.6% | — | ||
| Q3 24 | -4.2% | — | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | 60.4% | — | ||
| Q4 23 | 15.4% | — |
| Q3 25 | 1.6% | 0.2% | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 4.0% | — | ||
| Q4 23 | 1.8% | — |
| Q3 25 | -0.63× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.23× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NCMI
| National Advertising Revenue | $49.9M | 79% |
| Local Advertising Revenue | $9.6M | 15% |
| Founding Member Advertising Revenue From Beverage Concessionaire Agreements | $3.9M | 6% |
VRDN
Segment breakdown not available.
